Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02008526
Other study ID # R01DA035092
Secondary ID
Status Completed
Phase N/A
First received December 3, 2013
Last updated June 16, 2017
Start date January 2014
Est. completion date January 2017

Study information

Verified date June 2017
Source Friends Research Institute, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants receive culturally relevant and specifically tailored text messages based on the behavioral change theoretical constructs of Social Support Theory, Health Belief Model, and Social Cognitive Theory. Participants are randomized into one of three conditions for an 8-week intervention period: Group 1: culturally relevant theory-based text messages interactively transmitted by peer health educators (TXT-PHE); or, Group 2: the same culturally relevant theory-based text messages transmitted by automation (TXT-Auto); or, Group 3: assessment-only (AO) control with no theoretically based text messages.


Description:

The randomized three-group design uses repeated assessments at baseline, at the end of the 8-week intervention period, and at 3-, 6-, and 9-month post randomization follow-up. Participants in all three conditions receive brief weekly text-message assessments on their methamphetamine use and HIV sexual behaviors in the previous seven days. This study will determine the differential immediate and sustained effects of transmitting theory-based text messages by PHE (TXT-PHE) versus by automation (TXT-Auto), compared to an assessment-only (AO) control condition among out-of-treatment, methamphetamine-using MSM for reductions of methamphetamine use and HIV sexual risk behaviors. It is hypothesized that there will be significantly greater reductions in methamphetamine use and HIV sexual risk behaviors from text messages transmitted by PHE than by text messages transmitted by automation, which in turn will produce significantly greater reductions than the AO condition (PHE > TXT > AO). In addition, this study will determine the cost-effectiveness of TXT-PHE vs. TXT-Auto compared to AO for reducing methamphetamine use and HIV sexual risk behaviors. The investigators hypothesize that the TXT-PHE intervention will prove more cost-effective than TXT-Auto in reducing methamphetamine use and HIV sexual risk behaviors, while the TXT-Auto condition will prove more cost effective than the AO condition in reducing these same outcomes (PHE > TXT > AO).


Recruitment information / eligibility

Status Completed
Enrollment 286
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Self-identified MSM

- Between the ages of 18 and 65 years

- Methamphetamine use within the previous 3 months

- Unprotected anal intercourse (insertive or receptive) with a non-primary male partner in the previous 6 months

- Not currently in treatment or seeking methamphetamine abuse treatment

- Able and willing to fully charge a cellular phone daily

- Able and willing to provide informed consent

- Able and willing to comply with study requirements

Exclusion Criteria:

- Does not identify as a MSM

- Not between the ages of 18 and 65 years

- Has not used methamphetamine in the previous 3 months

- Has not had unprotected anal intercourse (insertive or receptive) with a non-primary male partner in the previous 6 months

- Currently in treatment or seeking methamphetamine abuse treatment

- Unable or unwilling to fully charge a cellular phone daily

- Unable or unwilling to provide informed consent

- Unable or unwilling to comply with study requirements

- Unable to understand the Informed Consent Form

- Determined to have a more serious psychiatric condition (SCID verified) that is beyond the safe enrollment of study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Text Messages Transmitted by Peer Health Educators (TXT-PHE)
Participants receive five gay-specific, theory-based pre-written messages per day sent on a predetermined schedule. Participants who respond to the pre-written text messages or initiate queries or requests for support ("pull") are sent additional real-time messages back from the PHE. Text messages are transmitted and responded to in real time, at the peak hours of high-risk activities. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days.
Text Messages Transmitted by Automation (TXT-Auto)
Participants receive five gay-specific, theory-based pre-written messages per day sent on a predetermined schedule. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days.

Locations

Country Name City State
United States Friends Community Center, a division of Friends Research Institute, Inc., Los Angeles, CA 90028 Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
Friends Research Institute, Inc. University of California, Los Angeles

Country where clinical trial is conducted

United States, 

References & Publications (2)

Reback CJ, Grant DL, Fletcher JB, Branson CM, Shoptaw S, Bowers JR, Charania M, Mansergh G. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS Behav. 2012 Oct;16(7):1993-2002. Erratum in: AIDS Behav. 2012 Oct;16(7):2003. — View Citation

Reback CJ, Ling D, Shoptaw S, Rohde J. Developing a Text Messaging Risk Reduction Intervention for Methamphetamine-Using MSM: Research Note. Open AIDS J. 2010 May 14;4:116-22. doi: 10.2174/1874613601004030116. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Methamphetamine Use Self-reported and/or biomarker-confirmed methamphetamine use assessed at baseline and 9-month follow-up assessment. 9-months post randomization
Primary HIV Sexual Risk Behavior Engagement in condomless anal intercourse was assessed at baseline and 9-month post-randomization follow-up. 9-months post randomization
Primary Cost Effectiveness Cost-effectiveness data is collected quarterly throughout the course of the study using the UNAIDS template. up to 36 months
Secondary HIV Primary Care HIV-positive participants will be assessed according to their linkage/retention in HIV primary care and adherence to ART medication at 8-weeks, 3-, 6-, and 9-months post-randomization. 8-weeks post randomization, 3-/6-/9-months post randomization
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2